Demoxepam
Pharmacokinetic data | |
---|---|
Elimination half-life | 35–40 hours |
Identifiers | |
| |
CAS Number | |
PubChem CID | |
ChemSpider | |
UNII | |
KEGG | |
ChEMBL | |
CompTox Dashboard (EPA) | |
ECHA InfoCard | 100.012.287 |
Chemical and physical data | |
Formula | C15H11ClN2O2 |
Molar mass | 286.71 g·mol−1 |
3D model (JSmol) | |
| |
| |
(what is this?) (verify) |
Demoxepam[1] is a drug which is a benzodiazepine derivative. It is a metabolite of chlordiazepoxide[2] and has anticonvulsant properties[3][4] and presumably other characteristic benzodiazepine properties.
See also
[edit]References
[edit]- ^ US Patent 3136815
- ^ Greenblatt DJ, Shader RI, MacLeod SM, Sellers EM (1978). "Clinical pharmacokinetics of chlordiazepoxide". Clinical Pharmacokinetics. 3 (5): 381–94. doi:10.2165/00003088-197803050-00004. PMID 359214.
- ^ "nortetrazepam". psychotropics.dk. 2003. Retrieved 7 December 2009.
- ^ "LIST OF INTERNATIONAL NON-PROPRIETARY NAMES (INNS), PROVIDED FOR PHARMACEUTICAL SUBSTANCES BY THE WORLD HEALTH ORGANIZATION, WHICH ARE FREE OF DUTY" (PDF). Official Journal of the European Communities. eur-lex.europa.eu. 23 October 2001. Retrieved 7 December 2009.